Search company, investor...

Stage

Unattributed VC | Dead

Total Raised

$17M

Last Raised

$17M

About Hainan Hailing Cemipharma Corp.

Pharmaceutical Company in China

Headquarters Location

6 Jinyu Road Hainan Haikou

Haikou, Hainan, 570206,

China

86 898 66772015 (ext.232)

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Hainan Hailing Cemipharma Corp. Patents

Hainan Hailing Cemipharma Corp. has filed 2 patents.

The 3 most popular patent topics include:

  • Bacterial diseases
  • Cephalosporin antibiotics
  • Chromatography
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/29/2021

Cephalosporin antibiotics, Chromatography, Thiazoles, Phenols, Tetrazoles

Application

Application Date

12/29/2021

Grant Date

Title

Related Topics

Cephalosporin antibiotics, Chromatography, Thiazoles, Phenols, Tetrazoles

Status

Application

Hainan Hailing Cemipharma Corp. Frequently Asked Questions (FAQ)

  • Where is Hainan Hailing Cemipharma Corp.'s headquarters?

    Hainan Hailing Cemipharma Corp.'s headquarters is located at 6 Jinyu Road, Haikou.

  • What is Hainan Hailing Cemipharma Corp.'s latest funding round?

    Hainan Hailing Cemipharma Corp.'s latest funding round is Unattributed VC.

  • How much did Hainan Hailing Cemipharma Corp. raise?

    Hainan Hailing Cemipharma Corp. raised a total of $17M.

  • Who are the investors of Hainan Hailing Cemipharma Corp.?

    Investors of Hainan Hailing Cemipharma Corp. include AIF Captial and Mitsui & Co. Global Investment.

  • Who are Hainan Hailing Cemipharma Corp.'s competitors?

    Competitors of Hainan Hailing Cemipharma Corp. include Neos Therapeutics, OcuNexus Therapeutics, GC-Rise Pharmaceutical, Peckforton Pharmaceuticals, Oceana Therapeutics and 13 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Hainan Hailing Cemipharma Corp. to Competitors

I
ISW Group

ISW Group is a pharmaceutical company that researches and aims to develop FDA approved topical products for the management and treatment of acute and chronic inflammatory skin conditions. ISW Group's research program focuses on acute and chronic dermatologic irritation and inflammation associated with dermatitis, Pseudofolliculitis barbae, burn care and wound healing.

QOL Medical Logo
QOL Medical

QOL Medical is a specialty pharmaceutical company focused on the gastrointestinal market.

O
OcuNexus Therapeutics

OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.

Azur Pharma Logo
Azur Pharma

Azur Pharma is a pharmaceutical company focused on the CNS, women's health and urology markets of the US.

S
SpePharm Holding

A European specialty pharmaceutical company dedicated to hospital and specialist drugs.SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market.

R
ROXRO Pharma

Roxro Pharma is an early-stage specialty pharmaceutical company dedicated to identifying, licensing, and developing compounds in specialized disease areas with significant sales potential, such as pain management. Roxro will pursue product development with the objective of commercializing these products. Niche products will not be developed by major pharmaceutical companies because they will not fuel their growth requirements. Foreign and biotechnology companies with compounds that have a limited sales potential will not be partnered with major pharmaceutical companies. Therefore there are a number of products not being developed even though they are efficacious, safe and satisfy an unmet medical need.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.